Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - CASH FROM OPERATIONS
Cash from Operations GLUE - Monte Rosa Therapeutics, Inc.
42 M
LAST VALUE
56.66%
2 YEAR CAGR
54.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR